{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T06:02:14Z","timestamp":1779948134077,"version":"3.53.1"},"reference-count":129,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":49,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["2021.06731.BD"],"award-info":[{"award-number":["2021.06731.BD"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["2022.09566.BD"],"award-info":[{"award-number":["2022.09566.BD"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Research Center of the Portuguese Oncology Institute of Porto","award":["PI 27-CI-IPOP-27-2016"],"award-info":[{"award-number":["PI 27-CI-IPOP-27-2016"]}]},{"name":"Research Center of the Portuguese Oncology Institute of Porto","award":["PI 27-CI-IPOP-27-2016"],"award-info":[{"award-number":["PI 27-CI-IPOP-27-2016"]}]},{"name":"Research Center of the Portuguese Oncology Institute of Porto","award":["PI 27-CI-IPOP-27-2016"],"award-info":[{"award-number":["PI 27-CI-IPOP-27-2016"]}]},{"name":"Research Center of the Portuguese Oncology Institute of Porto","award":["PI 27-CI-IPOP-27-2016"],"award-info":[{"award-number":["PI 27-CI-IPOP-27-2016"]}]},{"name":"Research Center of the Portuguese Oncology Institute of Porto","award":["PI 27-CI-IPOP-27-2016"],"award-info":[{"award-number":["PI 27-CI-IPOP-27-2016"]}]},{"name":"Research Center of the Portuguese Oncology Institute of Porto","award":["PI 27-CI-IPOP-27-2016"],"award-info":[{"award-number":["PI 27-CI-IPOP-27-2016"]}]},{"name":"Research Center of the Portuguese Oncology Institute of Porto","award":["PI 27-CI-IPOP-27-2016"],"award-info":[{"award-number":["PI 27-CI-IPOP-27-2016"]}]},{"name":"PORTO.CCC\u2014Porto.Comprehensive Cancer Center Raquel Seruca","award":["NORTE-01-0145-FEDER-072678"],"award-info":[{"award-number":["NORTE-01-0145-FEDER-072678"]}]},{"name":"PORTO.CCC\u2014Porto.Comprehensive Cancer Center Raquel Seruca","award":["NORTE-01-0145-FEDER-072678"],"award-info":[{"award-number":["NORTE-01-0145-FEDER-072678"]}]},{"name":"PORTO.CCC\u2014Porto.Comprehensive Cancer Center Raquel Seruca","award":["NORTE-01-0145-FEDER-072678"],"award-info":[{"award-number":["NORTE-01-0145-FEDER-072678"]}]},{"name":"PORTO.CCC\u2014Porto.Comprehensive Cancer Center Raquel Seruca","award":["NORTE-01-0145-FEDER-072678"],"award-info":[{"award-number":["NORTE-01-0145-FEDER-072678"]}]},{"name":"PORTO.CCC\u2014Porto.Comprehensive Cancer Center Raquel Seruca","award":["NORTE-01-0145-FEDER-072678"],"award-info":[{"award-number":["NORTE-01-0145-FEDER-072678"]}]},{"name":"PORTO.CCC\u2014Porto.Comprehensive Cancer Center Raquel Seruca","award":["NORTE-01-0145-FEDER-072678"],"award-info":[{"award-number":["NORTE-01-0145-FEDER-072678"]}]},{"name":"PORTO.CCC\u2014Porto.Comprehensive Cancer Center Raquel Seruca","award":["NORTE-01-0145-FEDER-072678"],"award-info":[{"award-number":["NORTE-01-0145-FEDER-072678"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-026-02868-2","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T13:48:15Z","timestamp":1775742495000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["From cell lines to the clinic: identifying a urinary BlCa-EV signature through comparative proteomics of bladder cancer lysates and extracellular vesicles"],"prefix":"10.1186","volume":"24","author":[{"given":"Catarina","family":"Louren\u00e7o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Const\u00e2ncio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuno Tiago","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Monteiro-Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Silva-Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Lobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c2ngela","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Jer\u00f3nimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"key":"2868_CR1","doi-asserted-by":"crossref","unstructured":"Bray FA-O et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin. 2024;74(3):229\u2013263..","DOI":"10.3322\/caac.21834"},{"key":"2868_CR2","doi-asserted-by":"publisher","first-page":"04109","DOI":"10.7189\/jogh.13.04109","volume":"13","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, et al. The global landscape of bladder cancer incidence and mortality in 2020 and projections to 2040. J Glob Health. 2023;13:04109.","journal-title":"J Glob Health"},{"issue":"1","key":"2868_CR3","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","volume":"9","author":"L Dyrskj\u00f8t","year":"2023","unstructured":"Dyrskj\u00f8t L, et al. Bladder cancer. Nat Rev Dis Primers. 2023;9(1):58.","journal-title":"Nat Rev Dis Primers"},{"key":"2868_CR4","doi-asserted-by":"publisher","first-page":"1170124","DOI":"10.3389\/fonc.2023.1170124","volume":"13","author":"K Grabe-Heyne","year":"2023","unstructured":"Grabe-Heyne K, et al. Intermediate and high-risk non-muscle-invasive bladder cancer: an overview of epidemiology, burden, and unmet needs. Front Oncol. 2023;13:1170124.","journal-title":"Front Oncol"},{"issue":"1","key":"2868_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/JU.0000000000003981","volume":"212","author":"J Holzbeierlein","year":"2024","unstructured":"Holzbeierlein J, et al. Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA\/ASCO\/SUO Guideline (2017; Amended 2020, 2024). J Urol. 2024;212(1):3\u201310.","journal-title":"J Urol"},{"key":"2868_CR6","doi-asserted-by":"publisher","first-page":"1453278","DOI":"10.3389\/fonc.2024.1453278","volume":"14","author":"M Ahangar","year":"2024","unstructured":"Ahangar M, Mahjoubi F, Mowla SJ. Bladder cancer biomarkers: current approaches and future directions. Front Oncol. 2024;14:1453278.","journal-title":"Front Oncol"},{"issue":"17","key":"2868_CR7","doi-asserted-by":"publisher","first-page":"4038","DOI":"10.7150\/jca.28989","volume":"10","author":"CZ Zhu","year":"2019","unstructured":"Zhu CZ, et al. A review on the accuracy of bladder cancer detection methods. J Cancer. 2019;10(17):4038\u201344.","journal-title":"J Cancer"},{"key":"2868_CR8","doi-asserted-by":"publisher","first-page":"1002301","DOI":"10.37349\/etat.2025.1002301","volume":"6","author":"D Godlewski","year":"2025","unstructured":"Godlewski D, et al. Bladder cancer biomarkers. Explor Target Antitumor Ther. 2025;6:1002301.","journal-title":"Explor Target Antitumor Ther"},{"issue":"1","key":"2868_CR9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.euf.2023.08.002","volume":"10","author":"W Devlies","year":"2024","unstructured":"Devlies W, et al. The Diagnostic Accuracy of Cystoscopy for Detecting Bladder Cancer in Adults Presenting with Haematuria: A Systematic Review from the European Association of Urology Guidelines Office. Eur Urol Focus. 2024;10(1):115\u201322.","journal-title":"Eur Urol Focus"},{"issue":"3","key":"2868_CR10","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s00345-009-0395-z","volume":"27","author":"KD Sievert","year":"2009","unstructured":"Sievert KD, et al. Economic aspects of bladder cancer: what are the benefits and costs? World J Urol. 2009;27(3):295\u2013300.","journal-title":"World J Urol"},{"issue":"1","key":"2868_CR11","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12964-023-01103-6","volume":"21","author":"YJ Liu","year":"2023","unstructured":"Liu YJ, Wang C. A review of the regulatory mechanisms of extracellular vesicles-mediated intercellular communication. Cell Commun Signal. 2023;21(1):77.","journal-title":"Cell Commun Signal"},{"issue":"12","key":"2868_CR12","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1038\/s41571-025-01074-2","volume":"22","author":"DW Greening","year":"2025","unstructured":"Greening DW, et al. Clinical relevance of extracellular vesicles in cancer - therapeutic and diagnostic potential. Nat Rev Clin Oncol. 2025;22(12):924\u201352.","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"2868_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0218-2","volume":"51","author":"R Bandu","year":"2019","unstructured":"Bandu R, Oh JW, Kim KP. Mass spectrometry-based proteome profiling of extracellular vesicles and their roles in cancer biology. Exp Mol Med. 2019;51(3):1\u201310.","journal-title":"Exp Mol Med"},{"issue":"1","key":"2868_CR14","doi-asserted-by":"publisher","first-page":"6801","DOI":"10.1038\/s41598-024-55251-x","volume":"14","author":"T Murakami","year":"2024","unstructured":"Murakami T, et al. Cross-sectional and longitudinal analyses of urinary extracellular vesicle mRNA markers in urothelial bladder cancer patients. Sci Rep. 2024;14(1):6801.","journal-title":"Sci Rep"},{"key":"2868_CR15","doi-asserted-by":"publisher","first-page":"1045624","DOI":"10.3389\/fimmu.2022.1045624","volume":"13","author":"S Wang","year":"2022","unstructured":"Wang S, et al. Tumor-derived extracellular vesicles modulate innate immune responses to affect tumor progression. Front Immunol. 2022;13:1045624.","journal-title":"Front Immunol"},{"key":"2868_CR16","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez-Cobos J et al. \u2206Np73, TAp73 and \u2206133p53 extracellular vesicle cargo as Early diagnosis markers in colorectal cancer. Cancers (Basel). 2021;13(9):2240.","DOI":"10.3390\/cancers13092240"},{"key":"2868_CR17","doi-asserted-by":"crossref","unstructured":"Witwer KW et al. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J Extracell Vesicles. 2013;2(1).","DOI":"10.3402\/jev.v2i0.20360"},{"key":"2868_CR18","doi-asserted-by":"crossref","unstructured":"Rontogianni S, et al. Proteomic profiling of extracellular vesicles allows for human breast cancer subtyping. Commun Biol. 2019;2:325.","DOI":"10.1038\/s42003-019-0570-8"},{"key":"2868_CR19","doi-asserted-by":"crossref","unstructured":"Dalla PV et al. Selectively-Packaged Proteins in Breast Cancer Extracellular Vesicles Involved in Metastasis. Int J Mol Sci, 2020;21(14):4990.","DOI":"10.3390\/ijms21144990"},{"issue":"3","key":"2868_CR20","doi-asserted-by":"publisher","first-page":"360","DOI":"10.20517\/evcna.2025.21","volume":"6","author":"J Ju","year":"2025","unstructured":"Ju J, et al. Extracellular vesicles: cargo loading, degradation and secretory pathways, and their intersection with autophagy. Extracell Vesicles Circ Nucl Acids. 2025;6(3):360\u201385.","journal-title":"Extracell Vesicles Circ Nucl Acids"},{"key":"2868_CR21","doi-asserted-by":"publisher","first-page":"38531","DOI":"10.1038\/srep38531","volume":"6","author":"JI Warrick","year":"2016","unstructured":"Warrick JI, et al. FOXA1, GATA3 and PPAR\u0263 Cooperate to Drive Luminal Subtype in Bladder Cancer: A Molecular Analysis of Established Human Cell Lines. Sci Rep. 2016;6:38531.","journal-title":"Sci Rep"},{"issue":"6","key":"2868_CR22","doi-asserted-by":"publisher","first-page":"656","DOI":"10.3906\/biy-2107-72","volume":"45","author":"A Eray","year":"2021","unstructured":"Eray A, Erkek-\u00d6zhan S. Classification of bladder cancer cell lines according to regulon activity. Turk J Biol. 2021;45(6):656\u201366.","journal-title":"Turk J Biol"},{"issue":"2","key":"2868_CR23","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3233\/BLC-180167","volume":"4","author":"TCM Zuiverloon","year":"2018","unstructured":"Zuiverloon TCM, et al. Systematic Review: Characteristics and Preclinical Uses of Bladder Cancer Cell Lines. Bladder Cancer. 2018;4(2):169\u201383.","journal-title":"Bladder Cancer"},{"issue":"4","key":"2868_CR24","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.cell.2020.07.009","volume":"182","author":"A Hoshino","year":"2020","unstructured":"Hoshino A, et al. Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers. Cell. 2020;182(4):1044\u2013e106118.","journal-title":"Cell"},{"issue":"1","key":"2868_CR25","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/s12964-025-02250-8","volume":"23","author":"NT Tavares","year":"2025","unstructured":"Tavares NT, et al. MicroRNA-371-373 cluster extracellular vesicle-based communication in testicular germ cell tumors. Cell Commun Signal. 2025;23(1):252.","journal-title":"Cell Commun Signal"},{"key":"2868_CR26","doi-asserted-by":"crossref","unstructured":"Os\u00f3rio H et al. Proteomics Analysis of Gastric Cancer Patients with Diabetes Mellitus. J Clin Med, 2021;10(3):407.","DOI":"10.3390\/jcm10030407"},{"issue":"2","key":"2868_CR27","doi-asserted-by":"publisher","first-page":"e12404","DOI":"10.1002\/jev2.12404","volume":"13","author":"JA Welsh","year":"2024","unstructured":"Welsh JA, et al. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches. J Extracell Vesicles. 2024;13(2):e12404.","journal-title":"J Extracell Vesicles"},{"key":"2868_CR28","doi-asserted-by":"crossref","unstructured":"Puttamallesh VN et al. Quantitative Proteomics of Urinary Bladder Cancer Cell Lines Identify UAP1 as a Potential Therapeutic Target. Genes (Basel). 2020;11(7).","DOI":"10.3390\/genes11070763"},{"issue":"4","key":"2868_CR29","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.jmb.2015.09.019","volume":"428","author":"S Keerthikumar","year":"2016","unstructured":"Keerthikumar S, et al. ExoCarta: A Web-Based Compendium of Exosomal Cargo. J Mol Biol. 2016;428(4):688\u201392.","journal-title":"J Mol Biol"},{"issue":"D1","key":"2868_CR30","doi-asserted-by":"publisher","first-page":"D1694","DOI":"10.1093\/nar\/gkad1007","volume":"52","author":"SV Chitti","year":"2024","unstructured":"Chitti SV, et al. Vesiclepedia 2024: an extracellular vesicles and extracellular particles repository. Nucleic Acids Res. 2024;52(D1):D1694\u20138.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2868_CR31","doi-asserted-by":"publisher","first-page":"4513","DOI":"10.1038\/s41467-024-48096-5","volume":"15","author":"FF Dressler","year":"2024","unstructured":"Dressler FF, et al. Proteomic analysis of the urothelial cancer landscape. Nat Commun. 2024;15(1):4513.","journal-title":"Nat Commun"},{"issue":"3","key":"2868_CR32","doi-asserted-by":"publisher","first-page":"882","DOI":"10.4143\/crt.2021.642","volume":"54","author":"J Suh","year":"2022","unstructured":"Suh J, et al. Next-generation Proteomics-Based Discovery, Verification, and Validation of Urine Biomarkers for Bladder Cancer Diagnosis. Cancer Res Treat. 2022;54(3):882\u201393.","journal-title":"Cancer Res Treat"},{"key":"2868_CR33","doi-asserted-by":"publisher","first-page":"1309842","DOI":"10.3389\/fonc.2024.1309842","volume":"14","author":"X Zhou","year":"2024","unstructured":"Zhou X, et al. Exploration of potential biomarkers for early bladder cancer based on urine proteomics. Front Oncol. 2024;14:1309842.","journal-title":"Front Oncol"},{"issue":"5","key":"2868_CR34","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1111\/cas.14881","volume":"112","author":"E Tomiyama","year":"2021","unstructured":"Tomiyama E, et al. Proteomic analysis of urinary and tissue-exudative extracellular vesicles to discover novel bladder cancer biomarkers. Cancer Sci. 2021;112(5):2033\u201345.","journal-title":"Cancer Sci"},{"issue":"3","key":"2868_CR35","doi-asserted-by":"publisher","first-page":"179","DOI":"10.14348\/molcells.2016.2359","volume":"41","author":"J Lee","year":"2018","unstructured":"Lee J, et al. Altered Proteome of Extracellular Vesicles Derived from Bladder Cancer Patients Urine. Mol Cells. 2018;41(3):179\u201387.","journal-title":"Mol Cells"},{"issue":"1","key":"2868_CR36","doi-asserted-by":"publisher","first-page":"5960","DOI":"10.1038\/s41598-020-62753-x","volume":"10","author":"S Hiltbrunner","year":"2020","unstructured":"Hiltbrunner S, et al. Urinary Exosomes from Bladder Cancer Patients Show a Residual Cancer Phenotype despite Complete Pathological Downstaging. Sci Rep. 2020;10(1):5960.","journal-title":"Sci Rep"},{"key":"2868_CR37","doi-asserted-by":"crossref","unstructured":"Jordaens S et al. Protein Biomarker Discovery Studies on Urinary sEV Fractions Separated with UF-SEC for the First Diagnosis and Detection of Recurrence in Bladder Cancer Patients. Biomolecules. 2023;13(6):932.","DOI":"10.3390\/biom13060932"},{"issue":"9","key":"2868_CR38","doi-asserted-by":"publisher","first-page":"3120","DOI":"10.1111\/cas.15438","volume":"113","author":"K Igami","year":"2022","unstructured":"Igami K, et al. Extracellular vesicles expressing CEACAM proteins in the urine of bladder cancer patients. Cancer Sci. 2022;113(9):3120\u201333.","journal-title":"Cancer Sci"},{"key":"2868_CR39","doi-asserted-by":"publisher","first-page":"34446","DOI":"10.1038\/srep34446","volume":"6","author":"SY Lin","year":"2016","unstructured":"Lin SY, et al. Proteome Profiling of Urinary Exosomes Identifies Alpha 1-Antitrypsin and H2B1K as Diagnostic and Prognostic Biomarkers for Urothelial Carcinoma. Sci Rep. 2016;6:34446.","journal-title":"Sci Rep"},{"issue":"12","key":"2868_CR40","doi-asserted-by":"publisher","first-page":"5611","DOI":"10.1021\/pr3008732","volume":"11","author":"CL Chen","year":"2012","unstructured":"Chen CL, et al. Comparative and targeted proteomic analyses of urinary microparticles from bladder cancer and hernia patients. J Proteome Res. 2012;11(12):5611\u201329.","journal-title":"J Proteome Res"},{"key":"2868_CR41","doi-asserted-by":"crossref","unstructured":"The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014;507(7492):315\u201322.","DOI":"10.1038\/nature12965"},{"issue":"4","key":"2868_CR42","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.eururo.2019.09.006","volume":"77","author":"A Kamoun","year":"2020","unstructured":"Kamoun A, et al. A Consensus Molecular Classification of Muscle-invasive Bladder Cancer. Eur Urol. 2020;77(4):420\u201333.","journal-title":"Eur Urol"},{"issue":"5","key":"2868_CR43","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.eururo.2021.10.035","volume":"81","author":"G Sj\u00f6dahl","year":"2022","unstructured":"Sj\u00f6dahl G, et al. Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes. Eur Urol. 2022;81(5):523\u201332.","journal-title":"Eur Urol"},{"issue":"3","key":"2868_CR44","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.cell.2017.09.007","volume":"171","author":"AG Robertson","year":"2017","unstructured":"Robertson AG, et al. Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer. Cell. 2017;171(3):540\u2013e55625.","journal-title":"Cell"},{"issue":"7","key":"2868_CR45","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41585-023-00847-7","volume":"21","author":"CC Guo","year":"2024","unstructured":"Guo CC, et al. Molecular profile of bladder cancer progression to clinically aggressive subtypes. Nat Rev Urol. 2024;21(7):391\u2013405.","journal-title":"Nat Rev Urol"},{"issue":"4","key":"2868_CR46","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.7150\/thno.107213","volume":"15","author":"N Sun","year":"2025","unstructured":"Sun N, et al. Unveiling urinary extracellular vesicle mRNA signature for early diagnosis and prognosis of bladder cancer. Theranostics. 2025;15(4):1272\u201384.","journal-title":"Theranostics"},{"issue":"1","key":"2868_CR47","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1038\/s41467-024-45995-5","volume":"15","author":"K Xu","year":"2024","unstructured":"Xu K, et al. Elevated extracellular matrix protein 1 in circulating extracellular vesicles supports breast cancer progression under obesity conditions. Nat Commun. 2024;15(1):1685.","journal-title":"Nat Commun"},{"issue":"1","key":"2868_CR48","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12964-024-01508-x","volume":"22","author":"VK Boddu","year":"2024","unstructured":"Boddu VK, et al. Targeting cancer-derived extracellular vesicles by combining CD147 inhibition with tissue factor pathway inhibitor for the management of urothelial cancer cells. Cell Commun Signal. 2024;22(1):129.","journal-title":"Cell Commun Signal"},{"issue":"8","key":"2868_CR49","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1002\/jex2.47","volume":"1","author":"M Prieto-Vila","year":"2022","unstructured":"Prieto-Vila M, et al. High-grade bladder cancer cells secrete extracellular vesicles containing miRNA-146a-5p and promotes angiogenesis. J Extracell Biol. 2022;1(8):e47.","journal-title":"J Extracell Biol"},{"issue":"4","key":"2868_CR50","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.3892\/mmr.2013.1634","volume":"8","author":"L Yang","year":"2013","unstructured":"Yang L, et al. Bladder cancer cell-derived exosomes inhibit tumor cell apoptosis and induce cell proliferation in vitro. Mol Med Rep. 2013;8(4):1272\u20138.","journal-title":"Mol Med Rep"},{"issue":"17","key":"2868_CR51","doi-asserted-by":"publisher","first-page":"23335","DOI":"10.18632\/oncotarget.8024","volume":"7","author":"CR Silvers","year":"2016","unstructured":"Silvers CR, et al. Identification of extracellular vesicle-borne periostin as a feature of muscle-invasive bladder cancer. Oncotarget. 2016;7(17):23335\u201345.","journal-title":"Oncotarget"},{"issue":"20","key":"2868_CR52","doi-asserted-by":"publisher","first-page":"5758","DOI":"10.1158\/0008-5472.CAN-13-3512","volume":"74","author":"MS Ostenfeld","year":"2014","unstructured":"Ostenfeld MS, et al. Cellular disposal of miR23b by RAB27-dependent exosome release is linked to acquisition of metastatic properties. Cancer Res. 2014;74(20):5758\u201371.","journal-title":"Cancer Res"},{"issue":"2","key":"2868_CR53","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.juro.2014.02.035","volume":"192","author":"CJ Beckham","year":"2014","unstructured":"Beckham CJ, et al. Bladder cancer exosomes contain EDIL-3\/Del1 and facilitate cancer progression. J Urol. 2014;192(2):583\u201392.","journal-title":"J Urol"},{"issue":"8","key":"2868_CR54","doi-asserted-by":"publisher","first-page":"e163","DOI":"10.1038\/oncsis.2015.21","volume":"4","author":"CA Franzen","year":"2015","unstructured":"Franzen CA, et al. Urothelial cells undergo epithelial-to-mesenchymal transition after exposure to muscle invasive bladder cancer exosomes. Oncogenesis. 2015;4(8):e163\u2013163.","journal-title":"Oncogenesis"},{"issue":"7","key":"2868_CR55","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1158\/1541-7786.MCR-17-0784","volume":"16","author":"C Ringuette Goulet","year":"2018","unstructured":"Ringuette Goulet C, et al. Exosomes Induce Fibroblast Differentiation into Cancer-Associated Fibroblasts through TGF\u03b2 Signaling. Mol Cancer Res. 2018;16(7):1196\u2013204.","journal-title":"Mol Cancer Res"},{"key":"2868_CR56","doi-asserted-by":"crossref","unstructured":"Louren\u00e7o C et al. Urinary extracellular vesicles as potential biomarkers for urologic cancers: an overview of current methods and advances. Cancers (Basel). 2021;13(7):1529.","DOI":"10.3390\/cancers13071529"},{"key":"2868_CR57","doi-asserted-by":"crossref","unstructured":"Webber J, Clayton A. How pure are your vesicles? Journal of Extracellular Vesicles, 2013;2(1).","DOI":"10.3402\/jev.v2i0.19861"},{"issue":"1","key":"2868_CR58","doi-asserted-by":"publisher","first-page":"12267","DOI":"10.1038\/s41598-024-62783-9","volume":"14","author":"A Teixeira-Marques","year":"2024","unstructured":"Teixeira-Marques A, et al. Improved recovery of urinary small extracellular vesicles by differential ultracentrifugation. Sci Rep. 2024;14(1):12267.","journal-title":"Sci Rep"},{"key":"2868_CR59","doi-asserted-by":"publisher","first-page":"204173142311746","DOI":"10.1177\/20417314231174609","volume":"14","author":"S Williams","year":"2023","unstructured":"Williams S, et al. Comparison of extracellular vesicle isolation processes for therapeutic applications. J Tissue Eng. 2023;14:20417314231174609.","journal-title":"J Tissue Eng"},{"issue":"1","key":"2868_CR60","first-page":"80","volume":"2","author":"Z Zhao","year":"2021","unstructured":"Zhao Z, et al. Isolation and analysis methods of extracellular vesicles (EVs). Extracell Vesicles Circ Nucl Acids. 2021;2(1):80\u2013103.","journal-title":"Extracell Vesicles Circ Nucl Acids"},{"issue":"7","key":"2868_CR61","doi-asserted-by":"publisher","first-page":"e12093","DOI":"10.1002\/jev2.12093","volume":"10","author":"U Erdbr\u00fcgger","year":"2021","unstructured":"Erdbr\u00fcgger U, et al. Urinary extracellular vesicles: A position paper by the Urine Task Force of the International Society for Extracellular Vesicles. J Extracell Vesicles. 2021;10(7):e12093.","journal-title":"J Extracell Vesicles"},{"issue":"11","key":"2868_CR62","doi-asserted-by":"publisher","first-page":"e70022","DOI":"10.1002\/jex2.70022","volume":"3","author":"MA Harding","year":"2024","unstructured":"Harding MA, et al. Uromodulin and the study of urinary extracellular vesicles. J Extracell Biol. 2024;3(11):e70022.","journal-title":"J Extracell Biol"},{"issue":"10","key":"2868_CR63","doi-asserted-by":"publisher","first-page":"101196","DOI":"10.1016\/j.xcrm.2023.101196","volume":"4","author":"SM Batool","year":"2023","unstructured":"Batool SM, et al. Extrinsic and intrinsic preanalytical variables affecting liquid biopsy in cancer. Cell Rep Med. 2023;4(10):101196.","journal-title":"Cell Rep Med"},{"issue":"1","key":"2868_CR64","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41525-021-00217-5","volume":"6","author":"HT Luo","year":"2021","unstructured":"Luo HT, et al. Dissecting the multi-omics atlas of the exosomes released by human lung adenocarcinoma stem-like cells. NPJ Genom Med. 2021;6(1):48.","journal-title":"NPJ Genom Med"},{"issue":"52","key":"2868_CR65","doi-asserted-by":"publisher","first-page":"86999","DOI":"10.18632\/oncotarget.13569","volume":"7","author":"SN Hurwitz","year":"2016","unstructured":"Hurwitz SN, et al. Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers. Oncotarget. 2016;7(52):86999\u20137015.","journal-title":"Oncotarget"},{"key":"2868_CR66","doi-asserted-by":"crossref","unstructured":"Morales-Sanfrutos J et al. Defining the reference proteomes for small extracellular vesicles and non-vesicular components. Nat Cell Biol. 2026;28(3):622\u201339.","DOI":"10.1038\/s41556-026-01878-z"},{"key":"2868_CR67","doi-asserted-by":"publisher","first-page":"36338","DOI":"10.1038\/srep36338","volume":"6","author":"A Cvjetkovic","year":"2016","unstructured":"Cvjetkovic A, et al. Detailed Analysis of Protein Topology of Extracellular Vesicles-Evidence of Unconventional Membrane Protein Orientation. Sci Rep. 2016;6:36338.","journal-title":"Sci Rep"},{"key":"2868_CR68","doi-asserted-by":"crossref","unstructured":"Kirkemo LL et al. Cell-surface tethered promiscuous biotinylators enable comparative small-scale surface proteomic analysis of human extracellular vesicles and cells. Elife. 2022;11:e73982","DOI":"10.7554\/eLife.73982"},{"issue":"13","key":"2868_CR69","doi-asserted-by":"publisher","first-page":"e12164","DOI":"10.1002\/jev2.12164","volume":"10","author":"A Rai","year":"2021","unstructured":"Rai A, et al. Proteomic dissection of large extracellular vesicle surfaceome unravels interactive surface platform. J Extracell Vesicles. 2021;10(13):e12164.","journal-title":"J Extracell Vesicles"},{"issue":"12","key":"2868_CR70","doi-asserted-by":"publisher","first-page":"e70020","DOI":"10.1002\/jev2.70020","volume":"13","author":"D Fochtman","year":"2024","unstructured":"Fochtman D, et al. Challenges of MS-based small extracellular vesicles proteomics. J Extracell Vesicles. 2024;13(12):e70020.","journal-title":"J Extracell Vesicles"},{"key":"2868_CR71","doi-asserted-by":"crossref","unstructured":"Mulcahy LA, Pink RC, Carter DR. Routes and mechanisms of extracellular vesicle uptake. J Extracell Vesicles. 2014;3(1):24641.","DOI":"10.3402\/jev.v3.24641"},{"issue":"9","key":"2868_CR72","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1021\/acs.jproteome.3c00302","volume":"22","author":"Z Hong","year":"2023","unstructured":"Hong Z, et al. Proteomic Profiling and Tumor Microenvironment Characterization Reveal Molecular and Immunological Hallmarks of Left-Sided and Right-Sided Colon Cancer Tumorigenesis. J Proteome Res. 2023;22(9):2973\u201384.","journal-title":"J Proteome Res"},{"issue":"2","key":"2868_CR73","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/gm529","volume":"6","author":"S Hanash","year":"2014","unstructured":"Hanash S, Schliekelman M. Proteomic profiling of the tumor microenvironment: recent insights and the search for biomarkers. Genome Med. 2014;6(2):12.","journal-title":"Genome Med"},{"issue":"6","key":"2868_CR74","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1074\/mcp.M000063-MCP201","volume":"9","author":"JL Welton","year":"2010","unstructured":"Welton JL, et al. Proteomics analysis of bladder cancer exosomes. Mol Cell Proteom. 2010;9(6):1324\u201338.","journal-title":"Mol Cell Proteom"},{"key":"2868_CR75","doi-asserted-by":"crossref","unstructured":"Oliveira MC et al. Urinary Biomarkers in Bladder Cancer: Where Do We Stand and Potential Role of Extracellular Vesicles. Cancers (Basel). 2020;12(6):1400.","DOI":"10.3390\/cancers12061400"},{"issue":"10","key":"2868_CR76","doi-asserted-by":"publisher","first-page":"e12518","DOI":"10.1002\/jev2.12518","volume":"13","author":"Y Lin","year":"2024","unstructured":"Lin Y, et al. Integrin \u03b16-containing extracellular vesicles promote lymphatic remodelling for pre-metastatic niche formation in lymph nodes via interplay with CD151. J Extracell Vesicles. 2024;13(10):e12518.","journal-title":"J Extracell Vesicles"},{"issue":"16","key":"2868_CR77","doi-asserted-by":"publisher","first-page":"26515","DOI":"10.18632\/oncotarget.15713","volume":"8","author":"S Kapil","year":"2017","unstructured":"Kapil S, et al. The cell polarity protein Scrib functions as a tumor suppressor in liver cancer. Oncotarget. 2017;8(16):26515\u201331.","journal-title":"Oncotarget"},{"issue":"5","key":"2868_CR78","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.urolonc.2011.03.012","volume":"31","author":"B Namdarian","year":"2013","unstructured":"Namdarian B, et al. Loss of APKC expression independently predicts tumor recurrence in superficial bladder cancers. Urol Oncol. 2013;31(5):649\u201355.","journal-title":"Urol Oncol"},{"issue":"10","key":"2868_CR79","doi-asserted-by":"publisher","first-page":"e2207693","DOI":"10.1002\/advs.202207693","volume":"10","author":"H Kim","year":"2023","unstructured":"Kim H, et al. Transferrin Receptor-Mediated Iron Uptake Promotes Colon Tumorigenesis. Adv Sci (Weinh). 2023;10(10):e2207693.","journal-title":"Adv Sci (Weinh)"},{"key":"2868_CR80","doi-asserted-by":"publisher","first-page":"1567216","DOI":"10.3389\/fonc.2025.1567216","volume":"15","author":"G Ren","year":"2025","unstructured":"Ren G, et al. TFRC promotes the proliferation, migration, and invasion of osteosarcoma cells by increasing the intracellular iron content and RRM2 expression. Front Oncol. 2025;15:1567216.","journal-title":"Front Oncol"},{"issue":"Pt 1","key":"2868_CR81","doi-asserted-by":"publisher","first-page":"133323","DOI":"10.1016\/j.ijbiomac.2024.133323","volume":"274","author":"J Qin","year":"2024","unstructured":"Qin J, et al. Expression of transferrin receptor\/TFRC protein in bladder cancer cell T24 and its role in inducing iron death in bladder cancer. Int J Biol Macromol. 2024;274(Pt 1):133323.","journal-title":"Int J Biol Macromol"},{"issue":"2","key":"2868_CR82","doi-asserted-by":"publisher","first-page":"150","DOI":"10.2174\/1874467212666191016124935","volume":"13","author":"S Bahrami","year":"2020","unstructured":"Bahrami S, et al. Discovering Therapeutic Protein Targets for Bladder Cancer Using Proteomic Data Analysis. Curr Mol Pharmacol. 2020;13(2):150\u201372.","journal-title":"Curr Mol Pharmacol"},{"issue":"19","key":"2868_CR83","doi-asserted-by":"publisher","first-page":"9412","DOI":"10.1016\/S0021-9258(18)48095-7","volume":"262","author":"RM Johnstone","year":"1987","unstructured":"Johnstone RM, et al. Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J Biol Chem. 1987;262(19):9412\u201320.","journal-title":"J Biol Chem"},{"issue":"5","key":"2868_CR84","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1080\/15548627.2022.2140557","volume":"19","author":"JO Gardner","year":"2023","unstructured":"Gardner JO, et al. LC3-dependent EV loading and secretion (LDELS) promotes TFRC (transferrin receptor) secretion via extracellular vesicles. Autophagy. 2023;19(5):1551\u201361.","journal-title":"Autophagy"},{"issue":"3","key":"2868_CR85","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/jnc.15019","volume":"155","author":"VS Mattera","year":"2020","unstructured":"Mattera VS, et al. Extracellular vesicles containing the transferrin receptor as nanocarriers of apotransferrin. J Neurochem. 2020;155(3):327\u201338.","journal-title":"J Neurochem"},{"issue":"1","key":"2868_CR86","doi-asserted-by":"publisher","first-page":"22429","DOI":"10.1038\/s41598-022-26747-1","volume":"12","author":"C Rattanasinchai","year":"2022","unstructured":"Rattanasinchai C, Navasumrit P, Ruchirawat M. Elevated ITGA2 expression promotes collagen type I-induced clonogenic growth of intrahepatic cholangiocarcinoma. Sci Rep. 2022;12(1):22429.","journal-title":"Sci Rep"},{"issue":"53","key":"2868_CR87","doi-asserted-by":"publisher","first-page":"30146","DOI":"10.18632\/oncotarget.25731","volume":"9","author":"AS Arun","year":"2018","unstructured":"Arun AS, Tepper CG, Lam KS. Identification of integrin drug targets for 17 solid tumor types. Oncotarget. 2018;9(53):30146\u201362.","journal-title":"Oncotarget"},{"issue":"1","key":"2868_CR88","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1186\/s12935-021-02114-4","volume":"21","author":"R Dai","year":"2021","unstructured":"Dai R, et al. Lnc-STYK1-2 regulates bladder cancer cell proliferation, migration, and invasion by targeting miR-146b-5p expression and AKT\/STAT3\/NF-kB signaling. Cancer Cell Int. 2021;21(1):408.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"2868_CR89","doi-asserted-by":"publisher","first-page":"18341","DOI":"10.1038\/s41598-023-44050-5","volume":"13","author":"CV Trinidad","year":"2023","unstructured":"Trinidad CV, et al. Lineage specific extracellular vesicle-associated protein biomarkers for the early detection of high grade serous ovarian cancer. Sci Rep. 2023;13(1):18341.","journal-title":"Sci Rep"},{"key":"2868_CR90","doi-asserted-by":"crossref","unstructured":"Ruzycka-Ayoush M et al. Extracellular vesicles as next-generation biomarkers in lung cancer patients: a case report on adenocarcinoma and squamous cell carcinoma. Life (Basel). 2024;14(3).","DOI":"10.3390\/life14030408"},{"issue":"23\u201324","key":"2868_CR91","doi-asserted-by":"publisher","first-page":"e2400058","DOI":"10.1002\/pmic.202400058","volume":"24","author":"B Ferrara","year":"2024","unstructured":"Ferrara B, et al. Matrix stiffness regulates the protein profile of extracellular vesicles of pancreatic cancer cell lines. Proteomics. 2024;24(23\u201324):e2400058.","journal-title":"Proteomics"},{"key":"2868_CR92","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ebiom.2019.07.068","volume":"47","author":"H Jin","year":"2019","unstructured":"Jin H, et al. N(6)-methyladenosine modification of ITGA6 mRNA promotes the development and progression of bladder cancer. EBioMedicine. 2019;47:195\u2013207.","journal-title":"EBioMedicine"},{"issue":"8","key":"2868_CR93","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1038\/s44321-024-00099-x","volume":"16","author":"A Gambelli","year":"2024","unstructured":"Gambelli A, et al. Author Correction: Platinum-induced upregulation of ITGA6 promotes chemoresistance and spreading in ovarian cancer. EMBO Mol Med. 2024;16(8):1981.","journal-title":"EMBO Mol Med"},{"issue":"1","key":"2868_CR94","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.yexcr.2019.03.022","volume":"379","author":"Y Wu","year":"2019","unstructured":"Wu Y, et al. ITGA6 and RPSA synergistically promote pancreatic cancer invasion and metastasis via PI3K and MAPK signaling pathways. Exp Cell Res. 2019;379(1):30\u201347.","journal-title":"Exp Cell Res"},{"issue":"2","key":"2868_CR95","doi-asserted-by":"publisher","first-page":"e2419712122","DOI":"10.1073\/pnas.2419712122","volume":"122","author":"JC Dubois","year":"2025","unstructured":"Dubois JC, et al. The single-stranded DNA-binding factor SUB1\/PC4 alleviates replication stress at telomeres and is a vulnerability of ALT cancer cells. Proc Natl Acad Sci U S A. 2025;122(2):e2419712122.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2868_CR96","doi-asserted-by":"publisher","first-page":"155369","DOI":"10.1016\/j.prp.2024.155369","volume":"259","author":"B Yan","year":"2024","unstructured":"Yan B, et al. PC4 promotes bladder cancer progression and stemness by directly interacting with Sp1 to transcriptionally activate the Wnt5a\/\u03b2-catenin pathway. Pathol Res Pract. 2024;259:155369.","journal-title":"Pathol Res Pract"},{"issue":"21","key":"2868_CR97","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.1111\/jcmm.17819","volume":"27","author":"Y Tan","year":"2023","unstructured":"Tan Y, Ding L, Li G. MCM4 acts as a biomarker for LUAD prognosis. J Cell Mol Med. 2023;27(21):3354\u201362.","journal-title":"J Cell Mol Med"},{"key":"2868_CR98","doi-asserted-by":"publisher","first-page":"1004324","DOI":"10.3389\/fonc.2022.1004324","volume":"12","author":"S Yang","year":"2022","unstructured":"Yang S, et al. MCM4 is a novel prognostic biomarker and promotes cancer cell growth in glioma. Front Oncol. 2022;12:1004324.","journal-title":"Front Oncol"},{"issue":"8","key":"2868_CR99","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.humpath.2005.06.008","volume":"36","author":"P Korkolopoulou","year":"2005","unstructured":"Korkolopoulou P, et al. Minichromosome maintenance proteins 2 and 5 expression in muscle-invasive urothelial cancer: a multivariate survival study including proliferation markers and cell cycle regulators. Hum Pathol. 2005;36(8):899\u2013907.","journal-title":"Hum Pathol"},{"issue":"1","key":"2868_CR100","doi-asserted-by":"publisher","first-page":"11003","DOI":"10.1038\/s41598-025-95505-w","volume":"15","author":"Y Zhu","year":"2025","unstructured":"Zhu Y, et al. Predictive and clinicopathological importance of HMGB2 in various carcinomas: a meta and bioinformatic approach. Sci Rep. 2025;15(1):11003.","journal-title":"Sci Rep"},{"issue":"3","key":"2868_CR101","doi-asserted-by":"publisher","first-page":"213","DOI":"10.4161\/cbt.23292","volume":"14","author":"YJ Shin","year":"2013","unstructured":"Shin YJ, et al. High-mobility group box 2 (HMGB2) modulates radioresponse and is downregulated by p53 in colorectal cancer cell. Cancer Biol Ther. 2013;14(3):213\u201321.","journal-title":"Cancer Biol Ther"},{"issue":"3","key":"2868_CR102","doi-asserted-by":"publisher","first-page":"884","DOI":"10.3892\/ol.2012.1091","volume":"5","author":"W Wang","year":"2013","unstructured":"Wang W, et al. Overexpression of high mobility group box 1 and 2 is associated with the progression and angiogenesis of human bladder carcinoma. Oncol Lett. 2013;5(3):884\u20138.","journal-title":"Oncol Lett"},{"issue":"1","key":"2868_CR103","doi-asserted-by":"publisher","first-page":"1781427","DOI":"10.1080\/20013078.2020.1781427","volume":"9","author":"MJ Boyer","year":"2020","unstructured":"Boyer MJ, et al. Endothelial cell-derived extracellular vesicles alter vascular smooth muscle cell phenotype through high-mobility group box proteins. J Extracell Vesicles. 2020;9(1):1781427.","journal-title":"J Extracell Vesicles"},{"issue":"9","key":"2868_CR104","doi-asserted-by":"publisher","first-page":"4114","DOI":"10.1021\/acs.jproteome.4c00490","volume":"23","author":"N Sharma","year":"2024","unstructured":"Sharma N, et al. Defining the Soluble and Extracellular Vesicle Protein Compartments of Plasma Using In-Depth Mass Spectrometry-Based Proteomics. J Proteome Res. 2024;23(9):4114\u201327.","journal-title":"J Proteome Res"},{"issue":"18","key":"2868_CR105","doi-asserted-by":"publisher","first-page":"26844","DOI":"10.18632\/oncotarget.8565","volume":"7","author":"L Yu","year":"2016","unstructured":"Yu L, et al. Critical role of DEK and its regulation in tumorigenesis and metastasis of hepatocellular carcinoma. Oncotarget. 2016;7(18):26844\u201355.","journal-title":"Oncotarget"},{"key":"2868_CR106","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/1471-2407-11-234","volume":"11","author":"A Datta","year":"2011","unstructured":"Datta A, et al. Oncoprotein DEK as a tissue and urinary biomarker for bladder cancer. BMC Cancer. 2011;11:234.","journal-title":"BMC Cancer"},{"issue":"5","key":"2868_CR107","doi-asserted-by":"publisher","first-page":"313","DOI":"10.55730\/1300-0152.2666","volume":"47","author":"L Xu","year":"2023","unstructured":"Xu L, et al. Ribosomal protein L8 regulates the expression and splicing pattern of genes associated with cancer-related pathways. Turk J Biol. 2023;47(5):313\u201324.","journal-title":"Turk J Biol"},{"issue":"12","key":"2868_CR108","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1038\/s43018-024-00847-5","volume":"5","author":"BK Tripathi","year":"2024","unstructured":"Tripathi BK, et al. The pro-oncogenic noncanonical activity of a RAS\u2022GTP:RanGAP1 complex facilitates nuclear protein export. Nat Cancer. 2024;5(12):1902\u201318.","journal-title":"Nat Cancer"},{"issue":"7","key":"2868_CR109","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s00018-022-04422-y","volume":"79","author":"S Chavan","year":"2022","unstructured":"Chavan S, et al. RanGTPase links nucleo-cytoplasmic transport to the recruitment of cargoes into small extracellular vesicles. Cell Mol Life Sci. 2022;79(7):392.","journal-title":"Cell Mol Life Sci"},{"issue":"13","key":"2868_CR110","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.7150\/ijbs.46751","volume":"16","author":"X Zheng","year":"2020","unstructured":"Zheng X, et al. Serine\/arginine-rich splicing factors: the bridge linking alternative splicing and cancer. Int J Biol Sci. 2020;16(13):2442\u201353.","journal-title":"Int J Biol Sci"},{"key":"2868_CR111","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.omtn.2021.02.019","volume":"24","author":"J Zeng","year":"2021","unstructured":"Zeng J, et al. CD46 splice variant enhances translation of specific mRNAs linked to an aggressive tumor cell phenotype in bladder cancer. Mol Ther Nucleic Acids. 2021;24:140\u201353.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"2868_CR112","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1186\/s12967-025-06547-7","volume":"23","author":"Q Wu","year":"2025","unstructured":"Wu Q, et al. SRSF1-mediated alternative splicing regulates bladder cancer progression and cisplatin sensitivity through HIF1A\/BNIP3\/mitophagy axis. J Transl Med. 2025;23(1):571.","journal-title":"J Transl Med"},{"issue":"6","key":"2868_CR113","doi-asserted-by":"publisher","first-page":"104414","DOI":"10.1016\/j.isci.2022.104414","volume":"25","author":"TY Chen","year":"2022","unstructured":"Chen TY, et al. Extracellular vesicles carry distinct proteo-transcriptomic signatures that are different from their cancer cell of origin. iScience. 2022;25(6):104414.","journal-title":"iScience"},{"issue":"9","key":"2868_CR114","doi-asserted-by":"publisher","first-page":"e1402","DOI":"10.1038\/cddis.2014.367","volume":"5","author":"L Lv","year":"2014","unstructured":"Lv L, et al. The DNA methylation-regulated miR-193a-3p dictates the multi-chemoresistance of bladder cancer via repression of SRSF2\/PLAU\/HIC2 expression. Cell Death Dis. 2014;5(9):e1402.","journal-title":"Cell Death Dis"},{"key":"2868_CR115","doi-asserted-by":"crossref","unstructured":"Samardzija P, et al. Defining the interactome of the pancreas-specific SPCA2 isoform (SPCA2C) identifies unique links to store-operated Ca(2+) entry. Febs J. 2025;(292):6644\u201369.","DOI":"10.1111\/febs.70213"},{"issue":"1","key":"2868_CR116","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1038\/s41467-025-57633-9","volume":"16","author":"Y Li","year":"2025","unstructured":"Li Y, et al. Urinary extracellular vesicle N-glycomics identifies diagnostic glycosignatures for bladder cancer. Nat Commun. 2025;16(1):2292.","journal-title":"Nat Commun"},{"issue":"1","key":"2868_CR117","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.eururo.2011.02.022","volume":"60","author":"NT Georgopoulos","year":"2011","unstructured":"Georgopoulos NT, et al. Immortalisation of normal human urothelial cells compromises differentiation capacity. Eur Urol. 2011;60(1):141\u20139.","journal-title":"Eur Urol"},{"issue":"4","key":"2868_CR118","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3233\/BLC-160065","volume":"2","author":"MJ Hoffmann","year":"2016","unstructured":"Hoffmann MJ, et al. The New Immortalized Uroepithelial Cell Line HBLAK Contains Defined Genetic Aberrations Typical of Early Stage Urothelial Tumors. Bladder Cancer. 2016;2(4):449\u201363.","journal-title":"Bladder Cancer"},{"issue":"10","key":"2868_CR119","doi-asserted-by":"publisher","first-page":"4567","DOI":"10.1073\/pnas.1803595116","volume":"116","author":"J Mullenders","year":"2019","unstructured":"Mullenders J, et al. Mouse and human urothelial cancer organoids: A tool for bladder cancer research. Proc Natl Acad Sci U S A. 2019;116(10):4567\u201374.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2868_CR120","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12014-023-09424-x","volume":"20","author":"AG Birhanu","year":"2023","unstructured":"Birhanu AG. Mass spectrometry-based proteomics as an emerging tool in clinical laboratories. Clin Proteom. 2023;20(1):32.","journal-title":"Clin Proteom"},{"issue":"7\u20138","key":"2868_CR121","doi-asserted-by":"publisher","first-page":"e2200238","DOI":"10.1002\/pmic.202200238","volume":"23","author":"EL Boys","year":"2023","unstructured":"Boys EL, et al. Clinical applications of mass spectrometry-based proteomics in cancer: Where are we? Proteomics. 2023;23(7\u20138):e2200238.","journal-title":"Proteomics"},{"issue":"3","key":"2868_CR122","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.cll.2018.05.002","volume":"38","author":"KL Lynch","year":"2018","unstructured":"Lynch KL. Accreditation and Quality Assurance for Clinical Liquid Chromatography-Mass Spectrometry Laboratories. Clin Lab Med. 2018;38(3):515\u201326.","journal-title":"Clin Lab Med"},{"key":"2868_CR123","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.clinbiochem.2020.03.004","volume":"82","author":"C Seger","year":"2020","unstructured":"Seger C, Salzmann L. After another decade: LC-MS\/MS became routine in clinical diagnostics. Clin Biochem. 2020;82:2\u201311.","journal-title":"Clin Biochem"},{"key":"2868_CR124","doi-asserted-by":"crossref","unstructured":"Arioz F, Tezcan S, Memboeuf A. The use of mass spectrometry in preclinical and clinical studies in oncology: a Mini Review. Analytical Letters. 2026;1\u201320.","DOI":"10.1080\/00032719.2026.2623512"},{"key":"2868_CR125","doi-asserted-by":"publisher","first-page":"118291","DOI":"10.1016\/j.trac.2025.118291","volume":"190","author":"Y Lu","year":"2025","unstructured":"Lu Y, et al. Recent progress in mass spectrometry-based liquid biopsy for cancer detection and analysis: A comprehensive review. TRAC Trends Anal Chem. 2025;190:118291.","journal-title":"TRAC Trends Anal Chem"},{"issue":"1","key":"2868_CR126","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12014-024-09452-1","volume":"21","author":"D Wenk","year":"2024","unstructured":"Wenk D, et al. Recent developments in mass-spectrometry-based targeted proteomics of clinical cancer biomarkers. Clin Proteomics. 2024;21(1):6.","journal-title":"Clin Proteomics"},{"issue":"13","key":"2868_CR127","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1158\/0008-5472.CAN-18-3538","volume":"79","author":"KDP Dorayappan","year":"2019","unstructured":"Dorayappan KDP, et al. A Microfluidic Chip Enables Isolation of Exosomes and Establishment of Their Protein Profiles and Associated Signaling Pathways in Ovarian Cancer. Cancer Res. 2019;79(13):3503\u201313.","journal-title":"Cancer Res"},{"issue":"1","key":"2868_CR128","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41467-017-02261-1","volume":"9","author":"E Re\u00e1tegui","year":"2018","unstructured":"Re\u00e1tegui E, et al. Engineered nanointerfaces for microfluidic isolation and molecular profiling of tumor-specific extracellular vesicles. Nat Commun. 2018;9(1):175.","journal-title":"Nat Commun"},{"issue":"1","key":"2868_CR129","doi-asserted-by":"publisher","first-page":"4489","DOI":"10.1038\/s41467-020-18311-0","volume":"11","author":"N Sun","year":"2020","unstructured":"Sun N, et al. Purification of HCC-specific extracellular vesicles on nanosubstrates for early HCC detection by digital scoring. Nat Commun. 2020;11(1):4489.","journal-title":"Nat Commun"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-026-02868-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-02868-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-02868-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T05:06:49Z","timestamp":1779944809000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12964-026-02868-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":129,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2868"],"URL":"https:\/\/doi.org\/10.1186\/s12964-026-02868-2","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,9]]},"assertion":[{"value":"15 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Samples were collected after obtaining patient informed consent and ethics approval (CES 174\/022).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"317"}}